2011•Biaoji mianyi fenxi yu linchuangRequires access

Clinical Significance of Measurement of T Lymphocyte Subsets in Peripheral Blood of Patients with Acute Myelogenous Leukemia

Zhiqing Li

Open publisher page 0 citations

Abstract

To evaluate the clinical significance of the changes of T lymphocyte subsets in patients with acute myeloid leukemia before and after therapy.Thirty acute myeloid leukemia patients who were confirmedly diagnosed but not treated were selected as new diagnosis group;Twenty-six patients completely remitted after chemical therapy was definite as complete remission group and 30 normal subjects were enrolled as control group.The changes of T lymphocyte subsets in three groups were examined by flow cytometry.The results showed that the ratio of CD3+T cells,CD4+T cells,CD8+T cells and CD4+/CD8+ in new diagnosis group were significantly different lower that that of complete remission group and controls(P0.05),and the ratio of CD4+T cells,CD8+T cells and CD4/CD8 in complete remission group were significantly lower than that of controls(P0.05).The cellular immune function of T lymphocyte is abnormal in patients with acute myelogenous leukemia,and the T lymphocyte subsets in patient of complete remission group are also lower than that of control group.

About this research paper

What this paper is about

To evaluate the clinical significance of the changes of T lymphocyte subsets in patients with acute myeloid leukemia before and after therapy.Thirty acute myeloid leukemia patients who were confirmedly diagnosed but not treated were selected as new diagnosis group;Twenty-six patients completely remitted after chemical therapy was definite as complete remission group and 30 normal subjects were enrolled as control group.The changes of T lymphocyte subsets in three groups were examined by flow cytometry.The results showed that the ratio of CD3+T cells,CD4+T cells,CD8+T cells and CD4+/CD8+ in new diagnosis group were significantly different lower that that of complete remission group and controls(P0.05),and the ratio of CD4+T cells,CD8+T cells and CD4/CD8 in complete remission group were significantly lower than that of controls(P0.05).The cellular immune function of T lymphocyte is abnormal in patients with acute myelogenous leukemia,and the T lymphocyte subsets in patient of complete remission group are also lower than that of control group.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To evaluate the clinical significance of the changes of T lymphocyte subsets in patients with acute myeloid leukemia before and after therapy.Thirty acute myeloid leukemia patients who were confirmedly diagnosed but not treated were selected as new diagnosis group;Twenty-six patients completely remitted after chemical therapy was definite as complete remission group and 30 normal subjects were enrolled as control group.The changes of T lymphocyte subsets in three groups were examined by flow cytometry.The results showed that the ratio of CD3+T cells,CD4+T cells,CD8+T cells and CD4+/CD8+ in new diagnosis group were significantly different lower that that of complete remission group and controls(P0.05),and the ratio of CD4+T cells,CD8+T cells and CD4/CD8 in complete remission group were significantly lower than that of controls(P0.05).The cellular immune function of T lymphocyte is abnormal in patients with acute myelogenous leukemia,and the T lymphocyte subsets in patient of complete remission group are also lower than that of control group.

Key concepts: Medicine, CD8, Myeloid leukemia, Leukemia, Immunology, CD3, Clinical significance, Immune system

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Significance of Measurement of T Lymphocyte Subsets in Peripheral Blood of Patients with Acute Myelogenous Leukemia — Research Paper | ScholarLens